A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects
Clinical trial NCT06563713 · COMPLETED
Trial details
- NCT number
- NCT06563713
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-02-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.